IOF Asia-Pacific Meeting presents new research and advances in osteoporosis management

December 13, 2012

Doctors and researchers from across the Asia-Pacific gathered today for the opening of the International Osteoporosis Foundation's (IOF) 3rd Asia-Pacific Osteoporosis Meeting, taking place at the Kuala Lumpur Convention Centre until December 16, 2012.

The Deputy Minister of Health of Malaysia, YB Datuk Rosnah bt. Hj. Abd. Rashid Shirlin, welcomed the delegates from more than 60 nations. His Excellency Tun Dato' Seri Utama (Dr.) Haji Abdul Rahman bin Haji Abbas, Governor of Penang, was also present.

Internationally acclaimed Malaysian actress and bone health advocate Dato Seri Michelle Yeoh, speaking at the Opening of the Meeting, urged the public to take action for bone health. She said, "I firmly believe that everyone, no matter their age or gender, should be taking action to look after their bone health in order to avoid developing diseases such as osteoporosis."

Osteoporosis is a disease which leads to weak and fragile bones that can break easily. Around the world up to one in two women and one in five men over the age of 50 will suffer a wrist, spine, hip or other fracture due to osteoporosis. The disease is a major cause of pain and disability, resulting in high healthcare and post-fracture rehabilitation costs. It is one of the most common diseases in older people, and in women over age 45 accounts for more days spent in hospital than many other diseases, including diabetes, heart attack and breast cancer.

During the four-day IOF Regionals 3rd Asia-Pacific Osteoporosis Meeting, delegates will hear about new research and the latest prevention and treatment strategies for osteoporosis. The Meeting is organized by IOF in partnership with the Malaysian Osteoporosis Society (MOS) and the Osteoporosis Awareness Society of Kuala Lumpur (OASKL).

Dr. Hew Fen Lee, Vice President of MOS and Dr. Lee Joon Kiong, President of OASKL also addressed delegates at the Opening Ceremony, highlighting the growing socieo-economic burden of fractures due to osteoporosis in Malaysia. Dr. Hew warned, "In the future Malaysia can expect a rise in the number of fractures due to osteoporosis, not just because of the growing percentage of older people within the population, but also due to the trend towards urbanization and more sedentary lifestyles."

Dr. Lee emphasized the significance of the IOF Asia-Pacific Osteoporosis Meeting for the fight against osteoporosis in Malaysia. "In order to address this significant health issue, we need to work together to implement community-based prevention strategies and to promote more research as well as public and health professional education programmes. We hope that this Meeting will serve as a catalyst for further progress in these areas."

The Chair of the IOF Asia-Pacific Regional Advisory Council and Scientific Co-Chair of the Meeting, Dr. Ambrish Mithal, remarked that over the past 30 years, the incidence of hip fracture has risen 2- to 3-fold in most Asian countries. "Osteoporosis, together with other related muscle and joint diseases, poses a serious and growing threat to the health and well-being of older adults in the Asia-Pacific region," he noted.

"It is expected that by 2050 more than 50% of all osteoporotic fractures will occur in Asia," said Professor John A. Kanis, President of IOF. "This meeting is an important regional venue for education and new research, both of which will help doctors work against the impending epidemic of fractures. We expect that the advanced clinical strategies communicated to the delegates at this meeting will ultimately result in improved patient care throughout the region."

The Meeting also serves to stimulate research from the Asia-Pacific region. Scientists from throughout Asia benefit from the opportunity to present their research at a high-profile venue with a large international audience. Research abstracts from the meeting are published in the field's leading journal, Osteoporosis International.

Research awards for young investigators and a Young Investigator Mentoring Programme further provide valuable opportunities for recognition of research excellence and scientific collaboration in the Asia-Pacific region.
-end-
About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization devoted to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members--including committees of scientific researchers, patient, medical and research societies, and industry representatives from around the globe--share a common vision of musculoskeletal health without fragility fractures. IOF now represents more than 200 societies in all regions of the world.

http://www.iofbonehealth.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.